These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
505 related items for PubMed ID: 9467133
1. GH and GnRH analog treatment in children who enter puberty at short stature. Tanaka T, Satoh M, Yasunaga T, Horikawa R, Tanae A, Hibi I. J Pediatr Endocrinol Metab; 1997; 10(6):623-8. PubMed ID: 9467133 [Abstract] [Full Text] [Related]
4. Final height after combined growth hormone and gonadotrophin-releasing hormone analogue therapy in short healthy children entering into normally timed puberty. Lanes R, Gunczler P. Clin Endocrinol (Oxf); 1998 Aug; 49(2):197-202. PubMed ID: 9828907 [Abstract] [Full Text] [Related]
5. Accelerated versus slowly progressive forms of puberty in girls with precocious and early puberty. Gonadotropin suppressive effect and final height obtained with two different analogs. Lanes R, Soros A, Jakubowicz S. J Pediatr Endocrinol Metab; 2004 May; 17(5):759-66. PubMed ID: 15237711 [Abstract] [Full Text] [Related]
7. Puberty and Pubertal Growth in GH-treated SGA Children: Effects of 2 Years of GnRHa Versus No GnRHa. van der Steen M, Lem AJ, van der Kaay DC, Hokken-Koèelega AC. J Clin Endocrinol Metab; 2016 May; 101(5):2005-12. PubMed ID: 26964733 [Abstract] [Full Text] [Related]
10. Adult height in girls with central precocious puberty treated with gonadotropin-releasing hormone analogues and growth hormone. Pasquino AM, Pucarelli I, Segni M, Matrunola M, Cerroni F. J Clin Endocrinol Metab; 1999 Feb; 84(2):449-52. PubMed ID: 10022399 [Abstract] [Full Text] [Related]
12. Effect of central precocious puberty and gonadotropin-releasing hormone analogue treatment on peak bone mass and final height in females. Bertelloni S, Baroncelli GI, Sorrentino MC, Perri G, Saggese G. Eur J Pediatr; 1998 May; 157(5):363-7. PubMed ID: 9625331 [Abstract] [Full Text] [Related]
13. Combined therapy with GnRH analog plus growth hormone in central precocious puberty. Pucarelli I, Segni M, Ortore M, Moretti A, Iannaccone R, Pasquino AM. J Pediatr Endocrinol Metab; 2000 Jul; 13 Suppl 1():811-20. PubMed ID: 10969926 [Abstract] [Full Text] [Related]
14. Effectiveness of the combined recombinant human growth hormone and gonadotropin-releasing hormone analog therapy in pubertal patients with short stature due to SHOX deficiency. Scalco RC, Melo SS, Pugliese-Pires PN, Funari MF, Nishi MY, Arnhold IJ, Mendonca BB, Jorge AA. J Clin Endocrinol Metab; 2010 Jan; 95(1):328-32. PubMed ID: 19926713 [Abstract] [Full Text] [Related]
15. Height prognosis of children with true precocious puberty and growth hormone deficiency: effect of combination therapy with gonadotropin releasing hormone agonist and growth hormone. Cara JF, Kreiter ML, Rosenfield RL. J Pediatr; 1992 May; 120(5):709-15. PubMed ID: 1533661 [Abstract] [Full Text] [Related]
16. Adult height in advanced puberty with or without gonadotropin hormone releasing hormone analog treatment. Couto-Silva AC, Adan L, Trivin C, Brauner R. J Pediatr Endocrinol Metab; 2002 Mar; 15(3):297-305. PubMed ID: 11924932 [Abstract] [Full Text] [Related]
17. Human growth hormone and gonadotropin releasing hormone analog combination therapy increases predicted height in short normal girls. Maniati-Christidi M, Livadas S, Voutetakis A, Tolis G, Dacou-Voutetakis C. Clin Pediatr (Phila); 2003 Mar; 42(1):59-65. PubMed ID: 12635983 [Abstract] [Full Text] [Related]
18. Anabolic steroid and gonadotropin releasing hormone analog combined treatment increased pubertal height gain and adult height in two children who entered puberty with short stature. Satoh M, Yokoya S. J Pediatr Endocrinol Metab; 2006 Sep; 19(9):1125-31. PubMed ID: 17128560 [Abstract] [Full Text] [Related]